Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Melanoma 21Breast Neoplasms 19Prostatic Neoplasms 12Neuroblastoma 11Multiple Myeloma 11Leukemia 11Leukemia, Myeloid, Acute 10Lymphoma 9Lymphoma, Non-Hodgkin 8Leukemia, Lymphocytic, Chronic, B-Cell 8Breast Neoplasms, Male 8Glioblastoma 7Ovarian Neoplasms 6Myelodysplastic Syndromes 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Fallopian Tube Neoplasms 5Colorectal Neoplasms 5Neoplasms 4Lymphoma, Follicular 4Leukemia, Myeloid, Chronic-Phase 4Hodgkin Disease 4Glioma 4Carcinoma, Ovarian Epithelial 4Uveal Melanoma 3Rhabdomyosarcoma 3Pancreatic Neoplasms 3Medulloblastoma 3Lung Neoplasms 3

Interventions

Ipilimumab 16incomplete Freund's adjuvant 9Nivolumab 9sargramostim 6Temozolomide 6Dacarbazine 6montanide ISA 51 5MART-1 Antigen 5Blood Specimen Collection 5pembrolizumab 4Ranibizumab 4Melphalan 4Interleukin-2 4Carboplatin 4CTLA-4 Antigen 4Thalidomide 3Surveys and Questionnaires 3MAGEA3 protein, human 3Granulocyte-Macrophage Colony-Stimulating Factor 3AZD 6244 3sotrastaurin 2relatlimab 2gp100 Melanoma Antigen 2fludarabine phosphate 2fludarabine 2entinostat 2aflibercept 2Taxes 2Sunitinib 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Uveal Melanoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00661622 2025-05-16

Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF

Thomas Jefferson University

Phase 2 Completed
53 enrolled 12 charts
Dermatologic

Uveal Melanoma

NCT00471471 2017-06-22

Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

University of Pittsburgh

Phase 1 Completed
22 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT00089219 2014-11-20

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

University of Virginia

Phase 1/2 Completed
39 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡